Literature DB >> 34924456

Medium-Term Impact of the Coronavirus Disease 2019 Pandemic on the Practice of Percutaneous Coronary Interventions in Japan.

Shusuke Watanabe1, Jung-Ho Shin1, Tetsuji Morishita1, Daisuke Takada1, Susumu Kunisawa1, Yuichi Imanaka1.   

Abstract

AIMS: Declines in cardiovascular diseases during the first surge of coronavirus disease 2019 (COVID-19) have been reported. With the repeating surges of COVID-19, we aim to investigate the medium-term impact of the COVID-19 pandemic on the practice of percutaneous coronary interventions (PCIs).
METHODS: We performed a descriptive analysis of rates of PCIs, utilizing administrative data in Japan. Changes in the proportion of severe cases and in-hospital mortality since the start of the COVID-19 pandemic were investigated using interrupted time series (ITS) analyses.
RESULTS: From April 2018 to February 2021, 38,696 and 28,585 cases of elective and emergency PCIs, respectively, were identified. The rates of PCIs decreased during the first and third COVID-19 surges. The ratios of monthly rates of elective PCIs to that in the corresponding months during the previous 2 years were 50.3% in May 2020 and 76.1% in January 2021. The decrease in rates of emergency PCIs was smaller than that of elective PCIs. The ITS analyses did not identify any significant changes in the proportion of severe cases and in-hospital mortality.
CONCLUSIONS: We found that the impacts of COVID-19 on PCIs were larger in the first surge than in the subsequent and larger in the elective than in the emergency; this continued over the medium-term. During the COVID-19 pandemic, in-hospital mortality of cases undertaking emergency PCIs did not change.

Entities:  

Keywords:  Acute myocardial infarction; COVID-19; Mortality rate; Percutaneous coronary intervention; Stable angina

Year:  2021        PMID: 34924456     DOI: 10.5551/jat.63194

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  2 in total

Review 1.  Cardiovascular considerations during the COVID-19 pandemic: A focused review for practice in Japan.

Authors:  Daiki Tomidokoro; Yukio Hiroi
Journal:  Glob Health Med       Date:  2022-04-30

2.  Impact of the COVID-19 Pandemic on the Use and Outcomes of Cardiac Procedures in COPD Patients.

Authors:  Javier de Miguel-Diez; Rodrigo Jimenez-Garcia; Jose M de Miguel-Yanes; Valentin Hernández-Barrera; David Carabantes-Alarcon; Jose J Zamorano-Leon; Concepción Noriega; Ana Lopez-de-Andres
Journal:  J Clin Med       Date:  2022-07-05       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.